[1]
Aprilia, V., Sarmoko, Fareza, M.S., Baroroh, H.N. and Choironi, N.A. 2024. Evaluation of natural compounds as VEGFR-2 inhibitors for breast cancer therapy: insights from molecular docking and drug-likeness analysis. Pharmacy Reports. 4, 2 (Oct. 2024), 82. DOI:https://doi.org/10.51511/pr.82.